Skip to main content
Top
Published in: Intensive Care Medicine 2/2006

01-02-2006 | Editorial

Searching for the etiology of systemic inflammatory response syndrome: is SIRS occult endotoxemia?

Author: Joseph A. Carcillo

Published in: Intensive Care Medicine | Issue 2/2006

Login to get access

Excerpt

It has been estimated that as many as 60% of critically ill patients develop systemic inflammatory response syndrome (SIRS), manifested by tachycardia, tachypnea, fever, and/or leukocytosis [1]. When this response occurs in the presence of living infection, it is called sepsis. When it occurs in the absence of living infection, it is called SIRS. In Intensive Care Medicine Stephens and colleagues now continue their investigation into the immunological etiology of SIRS in critical illness [2]. They previously reported in this journal that mannose binding lectin (MBL) deficiency is a predisposing factor to the development of SIRS in children after trauma or noncardiac surgery. [3] This lectin is the immediate (first 12 h) soluble immune response to infection. It is responsible for antibody independent complement mediated localization and killing of microbes. When MBL is deficient, infection cannot be localized, and if unchecked for the first 12 h it spreads until the antibody mediated complement system is recruited. If this infection is alive then this spread of infection can be identified as culture positive sepsis. However, if the infection is dead, it can be identified as culture negative sepsis, or if the physician does not think the patient has infection, it can be identified as SIRS. When one thinks of the component of dead infection in humans most likely to cause SIRS, it is endotoxin. The human gastrointestinal tract contains 25 × 109 ng endotoxin as microflora [4]. Any perturbation of intestinal, portal system, or liver permeability can result in spilling of endotoxin into the circulation. If not localized by MBL, this endotoxin has an additional 12 h to spread and cause SIRS (Fig. 1).
Literature
1.
go back to reference Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123CrossRefPubMed Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123CrossRefPubMed
2.
go back to reference Stephens R, Fidler K, Wilson P, Barclay G, Mythen M, Dixon G, Turner M, Klein N, Peters M (2005) Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children. Intensive Care Med (http://dx.doi.org/10.1007/s00134-005-0019-z) Stephens R, Fidler K, Wilson P, Barclay G, Mythen M, Dixon G, Turner M, Klein N, Peters M (2005) Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children. Intensive Care Med (http://​dx.​doi.​org/​10.​1007/​s00134-005-0019-z)
3.
go back to reference Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ (2004) Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose binding lectin. Intensive Care Med 30:1263–1265CrossRef Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ (2004) Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose binding lectin. Intensive Care Med 30:1263–1265CrossRef
4.
go back to reference Stephens R, Mythen M (2000) Endotoxin immunization. Intensive Care Med 26:129–135CrossRef Stephens R, Mythen M (2000) Endotoxin immunization. Intensive Care Med 26:129–135CrossRef
5.
go back to reference Camus G, Poortmans J, Nys M, Deby-Dupont G, Duchateau J, Deby C, Lamy M (1997) Mild endotoxemia and the inflammatory response induced by a marathon. Clin Sci (Lond) 92:415–422 Camus G, Poortmans J, Nys M, Deby-Dupont G, Duchateau J, Deby C, Lamy M (1997) Mild endotoxemia and the inflammatory response induced by a marathon. Clin Sci (Lond) 92:415–422
6.
go back to reference Soong CV, Lewis HG, Halldiay MI, Rowlands BJ (1999) Intramucosal acidosis and the inflammatory response in acute pancreatitis. Am J Gastroenterol 94:2423–2429PubMedCrossRef Soong CV, Lewis HG, Halldiay MI, Rowlands BJ (1999) Intramucosal acidosis and the inflammatory response in acute pancreatitis. Am J Gastroenterol 94:2423–2429PubMedCrossRef
7.
go back to reference Kanwar K, Windsor ACJW, Welsh F, Barclay R, Guillou PJ, Reynolds JV (2000) Lack of correlation between failure of gut barrier function and septic complications after major upper gastrointestinal surgery. Ann Surg 231:88–95PubMedCrossRef Kanwar K, Windsor ACJW, Welsh F, Barclay R, Guillou PJ, Reynolds JV (2000) Lack of correlation between failure of gut barrier function and septic complications after major upper gastrointestinal surgery. Ann Surg 231:88–95PubMedCrossRef
8.
go back to reference Aydin NB, Gercekoglu H, Aksu B, Ozkul V, Sener T, Kiygil I, Turkoglu T, Cimen S, Babacan F, Demirtas M (2003) Endotoxemia in coronary artery bypass surgery: a comparison of the off-pump technique and conventional cardiopulmonary bypass. J Thorac Cardiovasc Surg 125:843–848PubMedCrossRef Aydin NB, Gercekoglu H, Aksu B, Ozkul V, Sener T, Kiygil I, Turkoglu T, Cimen S, Babacan F, Demirtas M (2003) Endotoxemia in coronary artery bypass surgery: a comparison of the off-pump technique and conventional cardiopulmonary bypass. J Thorac Cardiovasc Surg 125:843–848PubMedCrossRef
9.
go back to reference Freeman R, Gould FK (1985) Rises in antibody to enteric gram negative bacilli after open heart surgery: a possible mechanism for postoperative hyperpyrexia. Thorax 40:538–541PubMedCrossRef Freeman R, Gould FK (1985) Rises in antibody to enteric gram negative bacilli after open heart surgery: a possible mechanism for postoperative hyperpyrexia. Thorax 40:538–541PubMedCrossRef
10.
go back to reference Freeman R, Gould FK (1985) Prevention of fever and gram negative infection after open heart surgery by antiendotoxin. Thorax 40:846–848PubMed Freeman R, Gould FK (1985) Prevention of fever and gram negative infection after open heart surgery by antiendotoxin. Thorax 40:846–848PubMed
11.
go back to reference Andersen LW, Landow L, Back L, Jansen E, Baker S (1993) Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 21:210–217PubMedCrossRef Andersen LW, Landow L, Back L, Jansen E, Baker S (1993) Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 21:210–217PubMedCrossRef
12.
go back to reference Bennett-Guerrero E, Asuyo L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, King SA, Muhlbaier LH, Newman MF, Mythen MG (1997) Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277:646–650PubMedCrossRef Bennett-Guerrero E, Asuyo L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, King SA, Muhlbaier LH, Newman MF, Mythen MG (1997) Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277:646–650PubMedCrossRef
13.
go back to reference Rothenburger M, Soeparwata R, Deng MC, Berendes E, Schmid C, Tjan TD, Wilhelm MJ, Erren M, Bocker D, Scheld HH (2001) The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery. J Am Coll Cardiol 38:124–130PubMedCrossRef Rothenburger M, Soeparwata R, Deng MC, Berendes E, Schmid C, Tjan TD, Wilhelm MJ, Erren M, Bocker D, Scheld HH (2001) The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery. J Am Coll Cardiol 38:124–130PubMedCrossRef
14.
go back to reference Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN (1992) Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 20:1090–1096PubMedCrossRef Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN (1992) Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 20:1090–1096PubMedCrossRef
15.
go back to reference Khabar KSA, ElBarbary MA, Khouqeer F, Devol E, Al-Gain S, Al-Halees (1997) Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response /multiple organ dysfunction syndrome. Clin Immunol Immunopathol 85:97–103PubMedCrossRef Khabar KSA, ElBarbary MA, Khouqeer F, Devol E, Al-Gain S, Al-Halees (1997) Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response /multiple organ dysfunction syndrome. Clin Immunol Immunopathol 85:97–103PubMedCrossRef
16.
go back to reference Lequeier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannon PJ, Giroir BP (2000) Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 117:1706–1712PubMedCrossRef Lequeier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannon PJ, Giroir BP (2000) Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 117:1706–1712PubMedCrossRef
17.
go back to reference Mou SS, Haudek SB, Lequier L, Pena O, Leonard S, Hisashi N, Giroir B, Stromberg D (2002) Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med 39:827–832CrossRef Mou SS, Haudek SB, Lequier L, Pena O, Leonard S, Hisashi N, Giroir B, Stromberg D (2002) Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med 39:827–832CrossRef
18.
go back to reference Allen ML, Peters MJ, Goldman A, Elliott M, James I, Callard R, Klein NJ (2002) Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Critical Care Med 30:1140–1145CrossRef Allen ML, Peters MJ, Goldman A, Elliott M, James I, Callard R, Klein NJ (2002) Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Critical Care Med 30:1140–1145CrossRef
19.
go back to reference Bennett-Guerrero E, Barclay GR, Youssef ME, Hossain S, Vela-Cantos F, Andres LA, Poxton IR (2000) Exposure to Bacteroides fragilis endotoxin during cardiac surgery. Anesth Analg 90:819–823PubMedCrossRef Bennett-Guerrero E, Barclay GR, Youssef ME, Hossain S, Vela-Cantos F, Andres LA, Poxton IR (2000) Exposure to Bacteroides fragilis endotoxin during cardiac surgery. Anesth Analg 90:819–823PubMedCrossRef
20.
go back to reference Bouter H, Schippers EF, Luelmo SA, Versteegh MI, Ros P, Guiot HF, Frolich M, van Dissel JT (2002) No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med 30:38–43PubMedCrossRef Bouter H, Schippers EF, Luelmo SA, Versteegh MI, Ros P, Guiot HF, Frolich M, van Dissel JT (2002) No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med 30:38–43PubMedCrossRef
21.
go back to reference Friedrich I, Silber RE, Baumann B, Fisher C, Holzheimer RG (2002) IgM-enriched immunoglobulin preparation for immunoprophylaxis in cardiac surgery. Eur J Med Res 7:544–549PubMed Friedrich I, Silber RE, Baumann B, Fisher C, Holzheimer RG (2002) IgM-enriched immunoglobulin preparation for immunoprophylaxis in cardiac surgery. Eur J Med Res 7:544–549PubMed
22.
go back to reference Xia ZY, Zhan LY, He YH, Liu XY (2003) The effect of Shen-Fu on gastrointestinal tract injury and its potential mechanism during cardiopulmonary bypass in patients undergoing cardiac surgery. Chin J Traumatol 6:245–248PubMed Xia ZY, Zhan LY, He YH, Liu XY (2003) The effect of Shen-Fu on gastrointestinal tract injury and its potential mechanism during cardiopulmonary bypass in patients undergoing cardiac surgery. Chin J Traumatol 6:245–248PubMed
23.
go back to reference Xia ZY, Liu XY, Zhan LY, He YH, Luo T, Xia Z (2005) Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 130:258–264CrossRefPubMed Xia ZY, Liu XY, Zhan LY, He YH, Luo T, Xia Z (2005) Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 130:258–264CrossRefPubMed
24.
go back to reference Yndgaard S, Andersen LW, Andersen C, Petterson G, Baek L (2000) The effect of modified ultrafiltration on the amount of circulating endotoxins in children undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14:399–401PubMedCrossRef Yndgaard S, Andersen LW, Andersen C, Petterson G, Baek L (2000) The effect of modified ultrafiltration on the amount of circulating endotoxins in children undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14:399–401PubMedCrossRef
25.
go back to reference Barclay GR (1999) Endotoxin core antibodies: time for a reappraisal? Intensive Care Med 25:427–429PubMedCrossRef Barclay GR (1999) Endotoxin core antibodies: time for a reappraisal? Intensive Care Med 25:427–429PubMedCrossRef
Metadata
Title
Searching for the etiology of systemic inflammatory response syndrome: is SIRS occult endotoxemia?
Author
Joseph A. Carcillo
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 2/2006
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-005-0067-4

Other articles of this Issue 2/2006

Intensive Care Medicine 2/2006 Go to the issue